Caffeine as a substitute for Schedule II stimulants in hyperkinetic children

Children being treated with methylphenidate or dextroamphetamine for minimal brain dysfunction syndrome and subsequent hyperkinetic impulse disorder may develop annoying side effects. A pilot study substituting caffeine, in the form of two cups of regular coffee a day, suggests that caffeine may be a suitable alternative to Schedule II drugs. The author points out the advantages of treatment with caffeine and suggests some specific aspects for further studies in this area.